NCT03022214

Brief Summary

Since 1948, health has been defined as "a state of complete physical, mental and social well-being, and not merely the absence of disease and infirmity" . However, a growing school of thought suggests that health represents an ability to be adaptable and flexible in response to daily stressors. It has been proposed that instead, the view of health should be "towards the ability to adapt and self-manage in the face of social, physical and emotional challenges", which has been termed "resilience". The theory of "resilience" relates health to the body's capacity to manage daily stressors (such as physical activity or oxidative fluctuations) that challenge homeostasis, with the return to homeostasis resulting from several physiological stress responses. Although this is an all-encompassing model, and the effects of pathogens and other stress factors are also relevant, this study will centre on the physiological aspects on this theory, focussing on the disruption through exercise.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 10, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 16, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

March 22, 2017

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2018

Completed
Last Updated

December 12, 2018

Status Verified

December 1, 2018

Enrollment Period

11 months

First QC Date

January 10, 2017

Last Update Submit

December 11, 2018

Conditions

Keywords

Dietary supplementationExerciseIncrease ResilienceOxidative StressEfficacy

Outcome Measures

Primary Outcomes (1)

  • Markers of Oxidative Stress

    Plasma TBARS:Plasma TBARS will be measured by HPLC (High Performance Liquid Chromatography).

    18months

Secondary Outcomes (15)

  • Antioxidant enzyme activity

    18months

  • Marker of Oxidative Stress

    18months

  • Markers of Inflammation

    18months

  • Plasma Interleukin-6 (IL-6)

    18months

  • Plasma Tumour-Necrosis Factor - alpha (TNF-α)

    18months

  • +10 more secondary outcomes

Study Arms (2)

Placebo

EXPERIMENTAL

5 capsules of placebo (microcrystalline cellulose) taken once in the morning with breakfast and once in the evening with dinner for two days prior to the study supervised exercise period and then one dose taken on the morning of the exercise test with the first meal

Dietary Supplement: Placebo

Intervention

EXPERIMENTAL

For presentation to volunteers, the daily capsules will be divided into two servings, one serving to be taken in the morning with breakfast, and one serving to be taken in the evening with dinner. Each serving containing 5 capsules, as follows: * EnduraCell broccoli sprout powder: 3 capsules * Bulk Powders Green tea extract: 1 capsule * Bulk Powders Cinnamon Bark Extract: 1 capsule to be taken for two days prior to the study supervised exercise period and then one dose taken on the morning of the exercise test with the first meal

Dietary Supplement: Intervention

Interventions

PlaceboDIETARY_SUPPLEMENT

Microcrystalline cellulose capsules x 5 morning and night with meals for two days prior to exercise test and 5 capsules taken on the morning of the test with the first meal

Placebo
InterventionDIETARY_SUPPLEMENT

Daily capsules will be divided into two servings, one serving to be taken in the morning with breakfast, and one serving to be taken in the evening with dinner. Each serving containing 5 capsules, as follows: * EnduraCell broccoli sprout powder: 3 capsules * Bulk Powders Green tea extract: 1 capsule * Bulk Powders Cinnamon Bark Extract: 1 capsule taken for two days prior to exercise test and 5 capsules taken on the morning of the test with the first meal

Intervention

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy, recreationally active men and women aged 18-25 BMI 18.5-30
  • Healthy, recreationally active men and women aged 50-75 BMI 18.5-30

You may not qualify if:

  • Physician diagnosed diabetes or chronic disease including asthma
  • Pregnancy
  • Uncontrolled Hypertension
  • Musculo-skeletal problems
  • Use of some dietary supplements (e.g. antioxidants, fish oils, vitamins\_
  • Taking of prescription medicines
  • In the 18-25 group, Physical Activity levels below moderate (Moderate = greater than 2.5 and less than 5.0 hrs /week including 0.5-1.5 hr/week moderate to intense exercise)
  • In the 50-75 group, activity levels below the minimal recommendations for daily physical activity (less than 30 min/day, 5 days/week)
  • Participation in another research study
  • Not being able to speak or understand English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Aberdeen, The Rowett Institute

Aberdeen, AB25 2ZD, United Kingdom

Location

MeSH Terms

Conditions

Motor Activity

Interventions

Methods

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Baukje De Roos, Msc, PhD

    The Rowett Institute, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2017

First Posted

January 16, 2017

Study Start

March 22, 2017

Primary Completion

February 28, 2018

Study Completion

August 31, 2018

Last Updated

December 12, 2018

Record last verified: 2018-12

Data Sharing

IPD Sharing
Will not share

Locations